|

Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population

RECRUITINGN/ASponsored by LMU Klinikum
Actively Recruiting
PhaseN/A
SponsorLMU Klinikum
Started2024-04-01
Est. completion2027-04-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06634121

Summary

To investigate potential differences in procedural outcomes of both commercially available transcatheter edge-to-edge mitral valve repair devices in a non-selected clinical setting.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age equal or above 18 years
* Written consent
* Heart Team recommends M-TEER

Exclusion Criteria:

* Mitral Stenosis (MV mean PG \> 5 mmHg)
* Cardiogenic shock or hemodynamic instability at the time of intervention
* Active endocarditis
* Participant in another interventional cardiology study

Conditions4

Heart DiseaseHeart FailureMitral RegurgitationValvular Heart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.